The ClariSIGMAM is an innovative breast cancer prediction marker. It is a breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. Quantitative breast density is the main indicator in breast cancer screening and diagnosis.
The ClariSIGMAM is an innovative breast cancer prediction marker. It is a breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. Quantitative breast density is the main indicator in breast cancer screening and diagnosis. The powerful pre-trained deep learning model ensures to make consistent clinical decision marking in an objective and convenient way. Novel Deep Learning Technology provides a fully automated quantification for breast and mammary area and proportion density measurements. ClariSIGMAM is convenient with a smart workflow at an affordable cost.
Fully compliant with DICOM standards, ClariSIGMAM allows easy and seamless integration with digital mammography and PACS systems to aid radiologists in the assessment of breast tissue composition.
The software assesses the breast density of women and generates a breast density group information for the patient (BI-RADS A+B as fatty and BI-RADS C+D as dense) in accordance with the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) density classification scale.
CE, Korea MFDS and FDA approved.
ClariPi Inc. was founded in February 2015 to provide innovative solutions for the unmet needs in medical imaging fields through the convergence of intelligent big data computing and medical imaging technologies. ClariPi products were born through a long-term collaboration research between engineering and medical experts. ClariPi's products were designed to help medical imaging experts make confident decisions with clearer information and convenient decision guidance. We are providing innovative solutions to help medical experts cope with the rapidly changing landscape of 21st century healthcare services.
by Koios
Koios DS™ Breast is revolutionizing breast cancer diagnostics with AI-powered
by MICA AI Medical
An AI-driven solution designed for dense breast mammography. Pioneering in CEM,
Let’s collaborate to harness the transformative power of these advanced technologies, propelling your medical practice to unprecedented levels of diagnostic accuracy, efficiency, and patient care.
Redeem your demo!
